Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Maria Magdalena Barreca, Riccardo Alessandro & Chiara Corrado. (2023) Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway. International Journal of Molecular Sciences 24:11, pages 9236.
Crossref
Crossref
Ahmed Elfadadny, Rokaia F. Ragab, Rania Hamada, Soad K. Al Jaouni, Junjiang Fu, Shaker A. Mousa & Ali H. El-Far. (2023) Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety. Toxicology and Applied Pharmacology 461, pages 116405.
Crossref
Crossref
Bo Chen & Jing-Pu Zhang. (2022) Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination. Phytomedicine 101, pages 154130.
Crossref
Crossref
Samira Mozaffari, Saman Seyedabadi & Esmat Alemzadeh. (2022) Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence. Journal of Drug Delivery Science and Technology 67, pages 102984.
Crossref
Crossref
Michele Russo, Enrico Bono & Alessandra Ghigo. (2021) The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity. Current Heart Failure Reports 18:4, pages 180-190.
Crossref
Crossref
R.A. Syahputra, U. Harahap, A. Dalimunthe, M. Pandapotan & D. Satria. (2021) Protective effect of Vernonia amygdalina Delile against doxorubicin-induced cardiotoxicity. Heliyon 7:7, pages e07434.
Crossref
Crossref
Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra, Purushothaman Venkatratnam, Ponnulakshmi Rajagopal, Hema Palaniappan & Senthil Kumar Ganesan. (2021) Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytotherapy Research 35:6, pages 3059-3077.
Crossref
Crossref
Miroslava Šudomová, Kateřina Berchová-Bímová, Stefania Marzocco, Alena Liskova, Peter Kubatka & Sherif Hassan. (2021) Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 13:6, pages 1014.
Crossref
Crossref
Kamil Piska, Marek Jamrozik, Paulina Koczurkiewicz-Adamczyk, Adam Bucki, Paweł Żmudzki, Marcin Kołaczkowski & Elżbieta Pękala. (2021) Carbonyl reduction pathway in hepatic in vitro metabolism of anthracyclines: Impact of structure on biotransformation rate. Toxicology Letters 342, pages 50-57.
Crossref
Crossref
Zhen‐Zhen Wang, Kun Li, Anish R. Maskey, Weihua Huang, Anton A. Toutov, Nan Yang, Kamal Srivastava, Jan Geliebter, Raj Tiwari, Mingsan Miao & Xiu‐Min Li. (2021) A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study. The FASEB Journal 35:4.
Crossref
Crossref
Kadry M. Sadek, Sahar F. E. Mahmoud, Mohamed F. Zeweil & Tarek K. Abouzed. (2021)
Proanthocyanidin alleviates doxorubicin‐induced cardiac injury by inhibiting NF‐
k
B pathway and modulating oxidative stress, cell cycle, and fibrogenesis
. Journal of Biochemical and Molecular Toxicology 35:4.
Crossref
Crossref
Wenna Zhou, Jian Ouyang, Na Hu, Gang Li & Honglun Wang. (2021) Protective Effect of Two Alkaloids from Hippophae rhamnoides Linn. against Doxorubicin-Induced Toxicity in H9c2 Cardiomyoblasts. Molecules 26:7, pages 1946.
Crossref
Crossref
Olufunke Esan Olorundare, Adejuwon Adewale Adeneye, Akinyele Olubiyi Akinsola, Abayomi Mayowa Ajayi, Olalekan Ayodele Agede, Sunday Sokunle Soyemi, Alban Ikenna Mgbehoma, Ikechukwu Innocent Okoye, Ralph M. Albrecht, James Mukasa Ntambi & Peter Anthony Crooks. (2021) Therapeutic Potentials of Selected Antihypertensive Agents and Their Fixed-Dose Combinations Against Trastuzumab-Mediated Cardiotoxicity. Frontiers in Pharmacology 11.
Crossref
Crossref
Fatma H. Shaker, Marwa O. El-Derany, Sara A. Wahdan, Ebtehal El-Demerdash & Hala O. El-Mesallamy. (2021) Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats. Life Sciences 269, pages 119078.
Crossref
Crossref
Bruno M. Moukette, José P. Castelão-Baptista, Luciana Ferreira, Ana M. Silva, Rui F. Simões, Célia Cabral, Constant A. Pieme, Jeanne Y. Ngogang, Vilma A. Sardão & Paulo J. Oliveira. (2021) Afrostyrax lepidophyllus Mildbr. and Monodora myristica (Gaertn.) Dunal Extracts Decrease Doxorubicin Cytotoxicity on H9c2 Cardiomyoblasts. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Alexa N. Carrera, Marianne K.O. Grant & Beshay N. Zordoky. (2020) CYP1B1 as a therapeutic target in cardio-oncology. Clinical Science 134:21, pages 2897-2927.
Crossref
Crossref
Sudip Kumar Mandal, Amal Kumar Maji, Siddhartha Kumar Mishra, Pir Mohammad Ishfaq, Hari Prasad Devkota, Ana Sanches Silva & Niranjan Das. (2020) Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues. Pharmacological Research 160, pages 105085.
Crossref
Crossref
Solomon Habtemariam. (2020) Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization. Molecules 25:6, pages 1426.
Crossref
Crossref
Kamil Piska, Paulina Koczurkiewicz, Dawid Wnuk, Elżbieta Karnas, Adam Bucki, Katarzyna Wójcik-Pszczoła, Marek Jamrozik, Marta Michalik, Marcin Kołaczkowski & Elżbieta Pękala. (2019) Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition. Chemico-Biological Interactions 300, pages 40-48.
Crossref
Crossref
Wei Shi, Hongkuan Deng, Jianyong Zhang, Ying Zhang, Xiufang Zhang & Guozhen Cui. (2018) Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin. Molecules 23:6, pages 1486.
Crossref
Crossref
Xing-Xing FanElaine Lai-Han LeungYing XieZhong Qiu LiuYan Fang ZhengXiao Jun YaoLin Lin LuJian Lin WuJian-Xing HeZhong-Wen YuanJunJiang FuChun-Li WeiJun HuangDa Kai XiaoLian Xiang LuoZe Bo JiangYan-Ling ZhouRichard Kin-Ting KamLiang Liu. (2018)
Suppression of Lipogenesis
via
Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases
. Antioxidants & Redox Signaling 28:5, pages 339-357.
Crossref
Crossref
Chen Xiong, Yan‑Zhao Wu, Yu Zhang, Zi‑Xiao Wu, Xue‑Yan Chen, Ping Jiang, Hui‑Cai Guo, Ke‑Rang Xie, Ke‑Xin Wang & Su‑Wen Su. (2018) Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment. Oncology Letters.
Crossref
Crossref
Jie Yu, Changxi Wang, Qi Kong, Xiaxia Wu, Jin-Jian Lu & Xiuping Chen. (2018) Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine 40, pages 125-139.
Crossref
Crossref
Chan Ho Park, Se Eun Han, Il Seong Nam-Goong, Young Il Kim & Eun Sook Kim. (2018) Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways. Endocrinology and Metabolism 33:1, pages 121.
Crossref
Crossref
HH Mansour, M Eid & MB El-Arnaouty. (2017) Effect of silver nanoparticles synthesized by gamma radiation on the cytotoxicity of doxorubicin in human cancer cell lines and experimental animals. Human & Experimental Toxicology 37:1, pages 38-50.
Crossref
Crossref
Alok Chandra Bharti, Priyanka Rajan, Mohit Jadli, Deepti Pande, Tejveer Singh & Anjali Bhat. 2018. Role of Nutraceuticals in Chemoresistance to Cancer. Role of Nutraceuticals in Chemoresistance to Cancer
221
240
.
Ana R. Coelho, Tatiana R. Martins, Renata Couto, Cláudia Deus, Cláudia V. Pereira, Rui F. Simões, Albert A. Rizvanov, Filomena Silva, Teresa Cunha-Oliveira, Paulo J. Oliveira & Teresa L. Serafim. (2017) Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:11, pages 2904-2923.
Crossref
Crossref
Mohamed M. Abdel-Daim, Omnia E. kilany, Hesham A. Khalifa & Amal A. M. Ahmed. (2017) Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemotherapy and Pharmacology 80:4, pages 745-753.
Crossref
Crossref
Abdelrahman Ibrahim Abushouk, Ammar Ismail, Amr Muhammad Abdo Salem, Ahmed M. Afifi & Mohamed M. Abdel-Daim. (2017) Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy 90, pages 935-946.
Crossref
Crossref
Kamil Piska, Paulina Koczurkiewicz, Adam Bucki, Katarzyna Wójcik-Pszczoła, Marcin Kołaczkowski & Elżbieta Pękala. (2017) Metabolic carbonyl reduction of anthracyclines — role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Investigational New Drugs 35:3, pages 375-385.
Crossref
Crossref
Mohsen Imenshahidi & Hossein Hosseinzadeh. (2016)
Berberis Vulgaris
and Berberine: An Update Review
. Phytotherapy Research 30:11, pages 1745-1764.
Crossref
Crossref
Shreesh Ojha, Hasan Al Taee, Sameer Goyal, Umesh B. Mahajan, Chandrgouda R. Patil, D. S. Arya & Mohanraj Rajesh. (2016) Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity. Oxidative Medicine and Cellular Longevity 2016, pages 1-19.
Crossref
Crossref